541 related articles for article (PubMed ID: 30414734)
1. Advances in the Treatment of Sickle Cell Disease.
Kapoor S; Little JA; Pecker LH
Mayo Clin Proc; 2018 Dec; 93(12):1810-1824. PubMed ID: 30414734
[TBL] [Abstract][Full Text] [Related]
2. Emerging disease-modifying therapies for sickle cell disease.
Carden MA; Little J
Haematologica; 2019 Sep; 104(9):1710-1719. PubMed ID: 31413089
[TBL] [Abstract][Full Text] [Related]
3. Sickle Cell Disease: A Review.
Kavanagh PL; Fasipe TA; Wun T
JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
[TBL] [Abstract][Full Text] [Related]
4. Sickle cell disease: current treatment and emerging therapies.
Neumayr LD; Hoppe CC; Brown C
Am J Manag Care; 2019 Nov; 25(18 Suppl):S335-S343. PubMed ID: 31809007
[TBL] [Abstract][Full Text] [Related]
5. The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease.
Kassim AA; DeBaun MR
Expert Opin Pharmacother; 2014 Feb; 15(3):325-36. PubMed ID: 24392871
[TBL] [Abstract][Full Text] [Related]
6. Sickle cell disease: taking a multidisciplinary approach.
Apanah S; Rizzolo D
JAAPA; 2013 Aug; 26(8):28-33. PubMed ID: 24049937
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiology and treatment of sickle-cell disease].
van Beers EJ; Peters M; Biemond BJ
Ned Tijdschr Geneeskd; 2005 May; 149(21):1144-9. PubMed ID: 15940917
[TBL] [Abstract][Full Text] [Related]
8. Current and emerging treatments for sickle cell disease.
Monus T; Howell CM
JAAPA; 2019 Sep; 32(9):1-5. PubMed ID: 31460979
[TBL] [Abstract][Full Text] [Related]
9. Sickle cell disease: progress towards combination drug therapy.
Pace BS; Starlard-Davenport A; Kutlar A
Br J Haematol; 2021 Jul; 194(2):240-251. PubMed ID: 33471938
[TBL] [Abstract][Full Text] [Related]
10. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
Okam MM; Ebert BL
Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
[TBL] [Abstract][Full Text] [Related]
12. Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development.
Hoppe C; Neumayr L
Hematol Oncol Clin North Am; 2019 Jun; 33(3):355-371. PubMed ID: 31030807
[TBL] [Abstract][Full Text] [Related]
13. Red Blood Cells as Therapeutic Target to Treat Sickle Cell Disease.
Bhatt S; Argueta DA; Gupta K; Kundu S
Antioxid Redox Signal; 2024 Jun; 40(16-18):1025-1049. PubMed ID: 37975291
[No Abstract] [Full Text] [Related]
14. Emerging drugs for sickle cell anemia.
Singh PC; Ballas SK
Expert Opin Emerg Drugs; 2015 Mar; 20(1):47-61. PubMed ID: 25431087
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
Anderson N
Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
[TBL] [Abstract][Full Text] [Related]
16. Advances in sickle cell therapies in the hydroxyurea era.
Field JJ; Nathan DG
Mol Med; 2014 Dec; 20 Suppl 1(Suppl 1):S37-42. PubMed ID: 25549232
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials.
Ali MA; Ahmad A; Chaudry H; Aiman W; Aamir S; Anwar MY; Khan A
Exp Hematol; 2020 Dec; 92():11-18.e1. PubMed ID: 32841705
[TBL] [Abstract][Full Text] [Related]
18. Time to rethink haemoglobin threshold guidelines in sickle cell disease.
Ballas SK; Kuypers FA; Gordeuk VR; Hankins JS; Thompson AA; Vichinsky E
Br J Haematol; 2021 Nov; 195(4):518-522. PubMed ID: 34131897
[TBL] [Abstract][Full Text] [Related]
19. Investigational agents for sickle cell disease.
Okpala I
Expert Opin Investig Drugs; 2006 Aug; 15(8):833-42. PubMed ID: 16859388
[TBL] [Abstract][Full Text] [Related]
20. Insight into the complex pathophysiology of sickle cell anaemia and possible treatment.
Piccin A; Murphy C; Eakins E; Rondinelli MB; Daves M; Vecchiato C; Wolf D; Mc Mahon C; Smith OP
Eur J Haematol; 2019 Apr; 102(4):319-330. PubMed ID: 30664257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
